These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19438508)

  • 21. Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats.
    Batchelor DC; Lin H; Wen JY; Keven C; Van Zijl PL; Breier BH; Gluckman PD; Thomas GB
    Anal Biochem; 2003 Dec; 323(2):156-63. PubMed ID: 14656520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats.
    Krishnamurthi RV; Mathai S; Kim AH; Zhang R; Guan J
    Br J Pharmacol; 2009 Feb; 156(4):662-72. PubMed ID: 19154439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide.
    Sara VR; Carlsson-Skwirut C; Bergman T; Jörnvall H; Roberts PJ; Crawford M; Håkansson LN; Civalero I; Nordberg A
    Biochem Biophys Res Commun; 1989 Dec; 165(2):766-71. PubMed ID: 2574573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I).
    Smith PF
    IDrugs; 2003 Dec; 6(12):1173-7. PubMed ID: 14666428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).
    Lai MY; Brimble MA; Callis DJ; Harris PW; Levi MS; Sieg F
    Bioorg Med Chem; 2005 Jan; 13(2):533-48. PubMed ID: 15598574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and neuroprotective activity of analogues of glycyl-L-prolyl-L-glutamic acid (GPE) modified at the alpha-carboxylic acid.
    Trotter NS; Brimble MA; Harris PW; Callis DJ; Sieg F
    Bioorg Med Chem; 2005 Jan; 13(2):501-17. PubMed ID: 15598572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
    Guan J; Krishnamurthi R; Waldvogel HJ; Faull RL; Clark R; Gluckman P
    Brain Res; 2000 Mar; 859(2):286-92. PubMed ID: 10719076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and pharmacological evaluation of side chain modified glutamic acid analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).
    Brimble MA; Trotter NS; Harris PW; Sieg F
    Bioorg Med Chem; 2005 Jan; 13(2):519-32. PubMed ID: 15598573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulation.
    Burgos-Ramos E; Martos-Moreno GA; López MG; Herranz R; Aguado-Llera D; Egea J; Frechilla D; Cenarruzabeitia E; León R; Arilla-Ferreiro E; Argente J; Barrios V
    J Neurochem; 2009 Apr; 109(2):360-70. PubMed ID: 19220704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuroprotective effects of intramuscular insulin-like growth factor-I treatment in brain ischemic rats.
    Chang HC; Yang YR; Wang PS; Kuo CH; Wang RY
    PLoS One; 2013; 8(5):e64015. PubMed ID: 23717526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semax, an analog of ACTH
    Medvedeva EV; Dmitrieva VG; Limborska SA; Myasoedov NF; Dergunova LV
    Mol Genet Genomics; 2017 Jun; 292(3):635-653. PubMed ID: 28255762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.
    Guan J; Waldvogel HJ; Faull RL; Gluckman PD; Williams CE
    Neuroscience; 1999 Mar; 89(3):649-59. PubMed ID: 10199602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury.
    Saatman KE; Contreras PC; Smith DH; Raghupathi R; McDermott KL; Fernandez SC; Sanderson KL; Voddi M; McIntosh TK
    Exp Neurol; 1997 Oct; 147(2):418-27. PubMed ID: 9344566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
    Saura J; Curatolo L; Williams CE; Gatti S; Benatti L; Peeters C; Guan J; Dragunow M; Post C; Faull RL; Gluckman PD; Skinner SJ
    Neuroreport; 1999 Jan; 10(1):161-4. PubMed ID: 10094155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of Trifluoromethylated Proline and Surrogates into Peptides: Application to the Synthesis of Fluorinated Analogues of the Neuroprotective Glycine-Proline-Glutamate (GPE) Tripeptide.
    Simon J; Pytkowicz J; Lensen N; Chaume G; Brigaud T
    J Org Chem; 2016 Jul; 81(13):5381-92. PubMed ID: 27295509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents.
    Marinelli L; Fornasari E; Di Stefano A; Turkez H; Genovese S; Epifano F; Di Biase G; Costantini E; D'Angelo C; Reale M; Cacciatore I
    Bioorg Med Chem Lett; 2019 Jan; 29(2):194-198. PubMed ID: 30522955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperature during recovery.
    Guan J; Gunn AJ; Sirimanne ES; Tuffin J; Gunning MI; Clark R; Gluckman PD
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):513-9. PubMed ID: 10724116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptides: Potential neuroprotective agents in ischemic injury.
    Saklani P; Khan H; Gupta S; Kaur A; Singh TG
    Life Sci; 2022 Jan; 288():120186. PubMed ID: 34852271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (R)-α-Lipoyl-Gly-l-Pro-l-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease.
    Marinelli L; Fornasari E; Di Stefano A; Turkez H; Arslan ME; Eusepi P; Ciulla M; Cacciatore I
    Neuropeptides; 2017 Dec; 66():52-58. PubMed ID: 28993014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.